Minimally invasive procedure treats narrowed aortic valve, restores blood flow in the heart.

Physicians and team members at Carondelet St. Mary’s Hospital recently marked the completion of their 500th Transcatheter Aortic Valve Replacement (TAVR) procedures, a minimally invasive alternative to open-heart surgery for treating aortic stenosis.

“Reaching the 500^th TAVR milestone is a significant achievement for Carondelet St. Mary’s Hospital. It’s a testament to the advanced treatments we can provide our patients – positively impacting their quality of life and their health,” said Cardiovascular Services Medical Director Dr. Kapil Lotun. Carondelet St. Mary’s Hospital began offering TAVR procedures in early 2020.

Aortic stenosis is a narrowing of the aortic valve that obstructs blood flow to the heart and the rest of the body. The TAVR procedure helps improve heart function, allowing many patients to resume their previous activity levels.

The TAVR procedure involves inserting a new valve attached to a catheter, which is guided by the physician through the body via arteries (typically through an entry point in the leg). When the diseased aortic valve is reached, the replacement valve is deployed and secured in place.

“We are incredibly proud of our team for achieving this milestone,” he said. “Your health can’t wait, and to treat this number of patients reflects our commitment to providing safe, appropriate care for members of our community,” said Dr. Lotun.

Incidence of aortic valve stenosis increases with age, according to the FDA. As the aortic valve opening narrows, the heart must work harder to pump blood through the body. Occurring in about 3% of Americans over the age 75, severe aortic valve stenosis can cause fainting, chest pain, heart failure, irregular heart rhythms (arrhythmias), cardiac arrest or death.

The TAVR team at Carondelet St. Mary’s Hospital includes specialists in interventional cardiology and cardiac surgery who are experienced in complex cardiac procedures.

Medically necessary procedures like TAVR can be lifesaving and life altering treatment, noted Carondelet Health Network Chief Executive Officer Monica Vargas-Mahar.

“Performing more than 500 TAVRs shows that there is a need for our cardiovascular services, and the community trusts our Carondelet caregivers to provide safe, compassionate, quality care when lives are at stake,” said Vargas-Mahar.

For more information about cardiovascular services at Carondelet Health Network, click here.